Conor Medsystems clinical trials
Acquired by Johnson & Johnson
The registry lists 5 studies whose lead sponsor is Conor Medsystems. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 30, 2009.
Registry sponsor names on this page
- Conor Medsystems5 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Johnson & Johnson studies →
- Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)TerminatedNCT00440674Phase 4
Sponsor listed in the registry: Conor Medsystems · Conor Medsystems — acquired company within the Johnson & Johnson group
- CoStar Catheter System EvaluationTerminatedNCT00993785Phase 3
Sponsor listed in the registry: Conor Medsystems · Conor Medsystems — acquired company within the Johnson & Johnson group
- Multi-Center Clinical Trial: Evaluation of Effectiveness and SafetyTerminatedNCT00415961Not applicable
Sponsor listed in the registry: Conor Medsystems · Conor Medsystems — acquired company within the Johnson & Johnson group
- CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System EvaluationCompletedNCT00422435Phase 3
Sponsor listed in the registry: Conor Medsystems · Conor Medsystems — acquired company within the Johnson & Johnson group
- Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)TerminatedNCT00322543Phase 3
Sponsor listed in the registry: Conor Medsystems · Conor Medsystems — acquired company within the Johnson & Johnson group